2 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
Follow Immunosuppressive Agents: new trials by email Literature Review of Immunosuppressive Agents trials Research Report on Immunosuppressive Agents
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM CYNK001-IV, CYNK001-IT - Astrocytoma, Grade IV, Giant Cell Glioblastoma | Phase 1 | Terminated | Celularity Incorporated | 3 | 2020-10-01 | 2022-08-10 |
| Natural Killer Cell (CYNK-001) Infusions in Adults with AML CYNK-001 - Leukemia, Leukemia, Myeloid | Phase 1 | Terminated | Celularity Incorporated | 27 | 2020-03-12 | 2024-12-12 |
Glioblastoma (1) · Hematologic Diseases (1) · Hematologic Neoplasms (1) · Leukemia (1) · Leukemia, Myeloid (1) · Leukemia, Myeloid, Acute (1) · Neoplasm, Residual (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
Astrocytoma (1) · Glioma (1) · Hemic and Lymphatic Diseases (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Glandular and Epithelial (1) · Neoplasms, Nerve Tissue (1) · Neoplasms, Neuroepithelial (1) · Neoplastic Processes (1) · Neuroectodermal Tumors (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
United States (2)